PhotonPharma Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $500K

  • Investors
  • 2

PhotonPharma General Information

Description

Developer of cancer immunotherapy designed to present tumor antigens to the patient, triggering a multi-antigen immune response. The company's immunotherapy technology uses a novel process that inactivates tumor cells while leaving them alive, that is combined with an adjuvant, enabling patients to either treat existing cancer or prevent metastasis.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Research Innovation Center, 3185 Rampart Road
  • D 230
  • Fort Collins, CO 80521
  • United States
+1 (303)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Research Innovation Center, 3185 Rampart Road
  • D 230
  • Fort Collins, CO 80521
  • United States
+1 (303)

PhotonPharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PhotonPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 01-Sep-2026 $500K Completed Clinical Trials - Phase 1
4. Seed Round 21-Aug-2024 Completed Clinical Trials - Phase 1
3. Seed Round 03-Apr-2024 Completed Startup
2. Accelerator/Incubator 16-Nov-2023 $248K $3.16M Completed Stealth
1. Seed Round 29-Aug-2023 $2.91M $2.91M Completed Stealth
To view PhotonPharma’s complete valuation and funding history, request access »

PhotonPharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view PhotonPharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

PhotonPharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cancer immunotherapy designed to present tumor antigens to the patient, triggering a multi-antigen immune r
Drug Discovery
Fort Collins, CO
8 As of 2026

New Haven, CT
 

Allentown, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PhotonPharma Competitors (3)

One of PhotonPharma’s 3 competitors is Cybrexa Therapeutics, a Venture Capital-Backed company based in New Haven, CT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cybrexa Therapeutics Venture Capital-Backed New Haven, CT
Jubilant Therapeutics Corporation Allentown, PA
Lantern Pharma Formerly VC-backed Dallas, TX
You’re viewing 3 of 3 competitors. Get the full list »

PhotonPharma Patents

PhotonPharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026213360-A1 Cancer vaccine combination treatments Pending 01-Apr-2025
WO-2026180950-A1 Systems, devices, and methods for cell-based therapies Pending 25-Feb-2025

PhotonPharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PhotonPharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Colorado Venture Capital Authority Government
CSU Starta Corporation Minority
To view PhotonPharma’s complete investors history, request access »

PhotonPharma FAQs

  • When was PhotonPharma founded?

    PhotonPharma was founded in 2018.

  • Where is PhotonPharma headquartered?

    PhotonPharma is headquartered in Fort Collins, CO.

  • What is the size of PhotonPharma?

    PhotonPharma has 8 total employees.

  • What industry is PhotonPharma in?

    PhotonPharma’s primary industry is Drug Discovery.

  • Is PhotonPharma a private or public company?

    PhotonPharma is a Private company.

  • What is PhotonPharma’s current revenue?

    The current revenue for PhotonPharma is .

  • How much funding has PhotonPharma raised over time?

    PhotonPharma has raised $6.66M.

  • Who are PhotonPharma’s investors?

    Colorado Venture Capital Authority and CSU Starta have invested in PhotonPharma.

  • Who are PhotonPharma’s competitors?

    Cybrexa Therapeutics, Jubilant Therapeutics, and Lantern Pharma are competitors of PhotonPharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process